Maravai LifeSciences
MRVI
MRVI
184 hedge funds and large institutions have $284M invested in Maravai LifeSciences in 2025 Q1 according to their latest regulatory filings, with 42 funds opening new positions, 61 increasing their positions, 51 reducing their positions, and 40 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
184
Holders Change
–
Holders Change %
0%
% of All Funds
2.5%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.04%
New
42
Increased
61
Reduced
51
Closed
40
Calls
$1.82M
Puts
$1.49M
Net Calls
+$337K
Net Calls Change
-$1.52M
Top Buyers
| 1 |
MFS
Mirabella Financial Services
London,
United Kingdom
|
+$8.27M |
| 2 |
PCM
Philosophy Capital Management
Alamo,
California
|
+$5.73M |
| 3 |
Two Sigma Advisers
New York
|
+$4.47M |
| 4 |
Two Sigma Investments
New York
|
+$2.93M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$2.32M |
Top Sellers
| 1 |
Alyeska Investment Group
Chicago,
Illinois
|
-$29M |
| 2 |
Jennison Associates
New York
|
-$16.3M |
| 3 |
GT
Glenmede Trust
Philadelphia,
Pennsylvania
|
-$12.2M |
| 4 |
BAMCO Inc
New York
|
-$12M |
| 5 |
Massachusetts Financial Services
Boston,
Massachusetts
|
-$9.76M |
